EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Voxel S.A. (VOX) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Voxel S.A. PLN 196, price PLN 146, upside +34.3%, quality 59 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · PL · ISIN PLVOXEL00014

VS Broad data Sep 23, 2026

Voxel S.A.

VOX · WAR

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value 195.75 PLN · Undervalued (+34%)
!Quality 59/100
!Mixed Growth (revenue 5y +12.2 %/yr)
✓Solidly profitable · 18.2% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (12/14)
✓Wide moat 81/100
!Insider activity 45/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

181.57 PLN 29.56 PLN Fair Value 195.75 PLN Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range 29.56 PLN – 181.57 PLN · fair‑value band 96.02 PLN – 258.00 PLN · the 145.80 PLN price screens below the 195.75 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Voxel in your weekly email

Every Wednesday you see whether Voxel is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A.

Show more

Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.

Stock analysis

Voxel S.A. (VOX) currently trades at 145.80 PLN, while our model-based Fair Value estimate is 195.75 PLN, implying the stock looks roughly 25.5% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 230.55 PLN per share, and 18 of the 26 models we run sit above the 145.80 PLN price.

Bear case: the Asset-Based group reads lowest at 26.09 PLN, and 8 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: 96.02 PLN (bear) to 258.00 PLN (bull), the price of 145.80 PLN sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Voxel S.A. reported revenue of 584M PLN in FY2025 versus 443M PLN in FY2021, a compound +7.2%/yr. Reported net income was 98.5M PLN in FY2025, compounding +8.7%/yr from FY2021.

Key figures

Market cap 1.5B PLN (≈ $398M) · P/E ratio 3.9 · P/S ratio 0.66 · EPS (TTM) 37.47 PLN · Dividend yield 4.1% · Net margin 16.9% · Return on equity 25.8% · Return on assets (EBIT) 18.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 17% below its 52-week high and 55% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at 34%, VOX screens cheaper than that median.

Fair Value models

Bear 96.02 PLN Fair Value 195.75 PLN Bull 258.00 PLN
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (27.51 PLN per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 54.51 PLN 92.26 PLN 179.31 PLN 76
Growth DCF 52.57 PLN 95.82 PLN 156.28 PLN 76
EPV 83.95 PLN 95.42 PLN 104.98 PLN 74
All 26 models by family
DCF Models
FCF DCF 54.51 PLN 92.26 PLN 179.31 PLN 76
Owner Earnings 95.93 PLN 181.18 PLN 327.06 PLN 73
5Y Revenue Exit 95.20 PLN 193.99 PLN 337.98 PLN 69
5Y EBITDA Exit 134.85 PLN 282.47 PLN 482.16 PLN 72
5Y P/E Exit 113.57 PLN 234.97 PLN 385.06 PLN 68
10Y Revenue Exit 75.55 PLN 160.79 PLN 310.02 PLN 63
10Y EBITDA Exit 104.09 PLN 222.84 PLN 429.29 PLN 64
10Y P/E Exit 90.75 PLN 189.53 PLN 348.97 PLN 60
Earnings-Based
Graham-Dodd 63.80 PLN 380.69 PLN 530.45 PLN 63
Lynch FV 108.36 PLN 154.80 PLN 201.24 PLN 61
PEG = 1.0 108.36 PLN 154.80 PLN 201.24 PLN 57
EPV 83.95 PLN 95.42 PLN 104.98 PLN 74
Dividend Discount
Gordon GGM 35.30 PLN 63.61 PLN 87.57 PLN 68
DDM Multi-Stage 35.30 PLN 58.11 PLN 67.95 PLN 67
Multiples
P/E Multiple 154.80 PLN 206.40 PLN 258.00 PLN 63
P/S Multiple 119.62 PLN 159.49 PLN 199.36 PLN 58
P/B Multiple 119.62 PLN 159.49 PLN 199.36 PLN 55
EV/EBIT 163.01 PLN 217.41 PLN 271.82 PLN 66
EV/EBITDA 189.34 PLN 252.53 PLN 315.71 PLN 67
EV/Revenue 116.28 PLN 166.21 PLN 216.13 PLN 53
Asset-Based
NCAV (Graham) 19.47 PLN 26.09 PLN 38.93 PLN 54
Growth DCF
Growth DCF 52.57 PLN 95.82 PLN 156.28 PLN 76
Rev-Margin DCF 95.20 PLN 188.64 PLN 320.12 PLN 70
Economic Profit
Residual Income 52.21 PLN 67.08 PLN 223.42 PLN 64
ROIC Compounder 97.38 PLN 128.49 PLN 167.37 PLN 72
Growth Earnings
Growth-Adj P/E 161.38 PLN 230.55 PLN 299.71 PLN 67

Open the full fair value analysis →

Notify me when VOX reaches fair value

Put VOX on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 59/100

Of which business quality 58 · Market factors (momentum, volatility) 58

Profitability 68
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 39
Earnings quality: real cash, not paper profit
Fin. Strength 76
Balance sheet, leverage, solvency risk
Investment 23
Disciplined investing over empire-building
Low Volatility 72
Calm price path (market factor)
Momentum 58
Price trend over the last 3–12 months (market factor)
52W Momentum 41
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 82/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.2%
Start year 2020 (pandemic). Over 10 years: +16.0% a year
Revenue growth 15 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.2%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+27.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+23.7%
Dividend (yield on the price)4.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.24% vs 23%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 23%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+24.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+5.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (Poland: IMF forecast 3.1% a year to 2030, 4.6% from 2016 to 2025) that is about +21.1% a year for the price and +1.8% for the forecasts.
Forecast 2026 (sales)+5.6%
Forecast 2027 (sales)+5.6%
Projected 2028 (sales)+5.1%
Projected 2029 (sales)+4.7%
Projected 2030 (sales)+4.2%

Watch VOX, get fair value alerts →

Compare Voxel S.A. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 143 stocks

Beats the industry median on 12/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 59 · Above median
Fair Value upside +34% · Top 25%
Profitability
Return on equity (TTM) 26% · Top 25%
Return on assets 13% · Top 25%
Net margin (TTM) 18% · Top 25%
Operating margin (TTM) 27% · Top 25%
Growth and dividend
Revenue growth 0% · Below median
Dividend yield (TTM) 4.1% · Top 25%
Balance sheet
Debt / equity 0.04× · Below median

Valuation Multiplesvs Diagnostics & Research median · lower = cheaper

P/E (TTM) 3.9× · Cheapest 25%
P/B 0.98× · Cheaper than median
P/S (TTM) 0.68× · Cheapest 25%
P/FCF 9.8× · Pricier than median
EV/EBITDA 2.3× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)79 · sector 0
FUTURE (revenue growth)0 · sector 25
PAST (return on equity)100 · sector 8
HEALTH (low debt)98 · sector 95
DIVIDEND (yield)83 · sector 30

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Thermo Fisher Scientific Inc TMO $665.30 $682.58 +3%
Danaher Corporation DHR $221.09 $207.76 −6%
WuXi AppTec Co 2359 HK$207.60 HK$228.36 +10%
Lonza Group LONN CHF 570.00 CHF 151.69 −73%
IDEXX Laboratories, Inc IDXX $522.02 $495.84 −5%
Agilent Technologies, Inc A $165.32 $63.90 −61%
Waters Corporation WAT $425.74 $106.31 −75%
IQVIA Holdings IQV $270.09 $295.80 +10%
Illumina, Inc ILMN $255.38 $280.92 +10%
Mettler-Toledo International Inc MTD $1,491 $635.75 −57%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Voxel S.A. Fair Value". https://www.fairvalue-calculator.com/stock/VOX

Frequently asked questions

Is Voxel S.A. (VOX) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 195.75 PLN versus a price of 145.80 PLN, about +34% upside (undervalued).
What is the fair value of VOX?
Our model-based fair value for Voxel S.A. is 195.75 PLN (as of Sep 23, 2026), built from audited fundamentals. The current price: 145.80 PLN.
What is the quality score of VOX?
Voxel S.A. has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Voxel S.A. (VOX)?
Our model-based price target is the fair value of 195.75 PLN (as of Sep 23, 2026) from 26 valuation models. Cautious scenario 96.02 PLN, optimistic scenario 258.00 PLN. It is a calculation from audited fundamentals, not an analyst target.
What is the Voxel S.A. stock forecast for 2026?
Our models put fair value at 195.75 PLN, about +34% upside versus a price of 145.80 PLN (undervalued). Cautious scenario 96.02 PLN, optimistic scenario 258.00 PLN. The calculation is refreshed regularly with new filings.
What is the revenue of Voxel S.A. (VOX)?
Voxel S.A. reported trailing-twelve-month revenue of about 583M PLN (latest available figure, as of Sep 23, 2026).
Does Voxel S.A. pay a dividend?
Voxel S.A. currently shows a dividend yield of about 4.13% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Voxel S.A. (VOX)?
For today's price to be fair in a discounted-cash-flow model, Voxel S.A. would have to grow free cash flow by +24.9 % per year for five years (discount rate 10.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.3 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of VOX use?
Our models discount Voxel S.A. at 10.8 %: a base by market capitalisation (small), damped by beta 0.57, country premium for Poland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Voxel S.A. that is +24.9 % per year a year over ten years, using the same discount rate (10.8 %) and the same formula as our fair value.
How much growth has Voxel S.A. (VOX) delivered so far?
Over the past 5 years revenue at Voxel S.A. grew +12.3 % a year. The price currently implies +24.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Voxel S.A. (VOX) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Voxel S.A. (+24.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Voxel S.A. (VOX)?
The free-cash-flow yield on the price is 2.67 %: that much free cash flow Voxel S.A. produces per unit of market value. When it exceeds the discount rate of our models (10.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Voxel S.A. (VOX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Voxel S.A. it is 195.75 PLN per share (as of Sep 23, 2026), against a price of 145.80 PLN. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Voxel S.A. stock overvalued or undervalued in 2026?
As of Sep 23, 2026, VOX trades below its calculated fair value: price 145.80 PLN, fair value 195.75 PLN, a gap of about +34% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VOX?
No. The price is what the market pays today (145.80 PLN); the fair value is what the company's own numbers justify (195.75 PLN). For Voxel S.A. the two are 49.95 PLN per share apart. That gap is exactly why we show both numbers side by side.
How much is Voxel S.A. worth?
The market values Voxel S.A. at about 1.5B PLN (market capitalisation, as of Sep 23, 2026). Per share that is 145.80 PLN; our models calculate a fair value of 195.75 PLN per share.
What do the bullish and bearish scenarios say about VOX?
Our models span a range for Voxel S.A.: cautious scenario 96.02 PLN, base 195.75 PLN, optimistic 258.00 PLN per share (as of Sep 23, 2026, price 145.80 PLN). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of VOX?
Voxel S.A. trades at a price-to-earnings ratio of 3.9 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 195.75 PLN is built from several models across several years. Other multiples: P/B 1.0, P/S 0.7, EV/EBITDA 2.3.
How solid is the balance sheet of Voxel S.A. (VOX)?
Balance-sheet figures for Voxel S.A. (as of Sep 23, 2026): return on equity 25.8%, debt of 0.04 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is VOX from its 52-week high?
Voxel S.A. trades at 145.80 PLN, about 17% below its 52-week high of 176.00 PLN and 55% above the low of 94.00 PLN (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 195.75 PLN is for.
Which stocks are comparable to Voxel S.A.?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Lonza Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Voxel S.A. stock attractive at the current price?
The data as of Sep 23, 2026: price 145.80 PLN, calculated fair value 195.75 PLN (+34%), Quality Score 59/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VOX calculated?
We run Voxel S.A. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 195.75 PLN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Voxel S.A. currently trades 34 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Voxel S.A. (VOX)?
The closing price on Sep 24, 2026 was 145.80 PLN. Our model-based fair value is 195.75 PLN, about +34% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Voxel S.A. right now?
The model range is unusually wide (96.02 PLN to 258.00 PLN). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality.
Where does the earnings growth of Voxel S.A. (VOX) come from?
Earnings per share at Voxel S.A. grew +25.9 % a year from 2015 to 2025. Broken into its drivers: revenue per share +17.7 %, EBIT margin +6.0 %, tax rate +0.4 %, residual (interest, one-offs) +0.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Voxel S.A.

How large is the market capitalisation of Voxel S.A. (VOX)?
The market capitalisation of Voxel S.A. is 1.5B PLN (≈ $398M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Voxel S.A. (VOX)?
The price-to-sales ratio of Voxel S.A. is 0.66 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Voxel S.A. (VOX)?
Earnings per share at Voxel S.A. are 37.47 PLN (price ÷ EPS = P/E 3.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Voxel S.A. (VOX)?
The dividend yield of Voxel S.A. is 4.1% (payout 16.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Voxel S.A. (VOX)?
The net margin of Voxel S.A. is 16.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Voxel S.A. (VOX)?
The return on equity (ROE) of Voxel S.A. is 25.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Voxel S.A. (VOX)?
On an EBIT basis the return on assets of Voxel S.A. is 18.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Voxel S.A. (VOX)?
The operating margin of Voxel S.A. is 27.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Voxel S.A. (VOX)?
Revenue at Voxel S.A. is growing −0.4% versus a year earlier (3y avg +12.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Voxel S.A. (VOX)?
Earnings per share at Voxel S.A. are growing +31.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Voxel S.A. (VOX) carry?
The net debt of Voxel S.A. is 43.2M PLN (fiscal year 2025, ≈ 1.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Voxel S.A. in the live analysis

One click puts Voxel S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.